Journal of Neurology最新文献

筛选
英文 中文
Detecting motor changes in treated adults with spinal muscular atrophy using both MFM-32 and patient-reported outcome: a 2-year real-world retrospective study. 使用MFM-32和患者报告的结果检测脊髓性肌萎缩症治疗成人的运动变化:一项为期2年的真实世界回顾性研究。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-14 DOI: 10.1007/s00415-026-14255-5
Maria Sframeli, Lucia Ruggiero, Dario Zoppi, Roberto Materia, Martina De Maria, Francesco Luppino, Elena La Rosa, Elvira D'Amico, Emanuela Fatima Taglialatela, Rosa Iodice, Sonia Messina
{"title":"Detecting motor changes in treated adults with spinal muscular atrophy using both MFM-32 and patient-reported outcome: a 2-year real-world retrospective study.","authors":"Maria Sframeli, Lucia Ruggiero, Dario Zoppi, Roberto Materia, Martina De Maria, Francesco Luppino, Elena La Rosa, Elvira D'Amico, Emanuela Fatima Taglialatela, Rosa Iodice, Sonia Messina","doi":"10.1007/s00415-026-14255-5","DOIUrl":"https://doi.org/10.1007/s00415-026-14255-5","url":null,"abstract":"<p><strong>Background: </strong>Risdiplam improves motor function in spinal muscular atrophy (SMA), especially in children. In adults, subtle changes may not be captured by standard motor scales.</p><p><strong>Objective: </strong>To describe 24-month motor outcomes, perceived global change, and safety of risdiplam in adults with SMA types 2 and 3 in routine practice.</p><p><strong>Methods: </strong>In this retrospective two-center study, MFM-32, HFMSE, and RULM were assessed at baseline and after 6, 12, and 24 months, and patient- and clinician-rated Clinical Global Impression (CGI) at 12 and 24 months.</p><p><strong>Results: </strong>All 24 patients (14 [58%] with SMA type 2) completed 24 months of risdiplam treatment. The median (min, max) MFM-32 score increased by 3 (- 2, 11) at 12 months (p < 0.001) and by 3 (- 8, 14) at 24 months (p = 0.004), whereas median HFMSE and RULM changes were 0 at both time points and did not remain significant after Holm correction. At 24 months, a clinically meaningful improvement was observed in 14/24 (58%) patients on the MFM-32, 3/24 (13%) on the HFMSE, and 7/24 (29%) on the RULM; 20/24 (83%) rated themselves as improved compared with baseline on the CGI, mostly minimally.</p><p><strong>Conclusions: </strong>In this real-world cohort of adults with advanced SMA, 24 months of risdiplam treatment were associated with motor stability and, in more than half of patients, with clinically meaningful improvement, whereas natural history would predict progressive decline. The MFM-32 captured this improvement better than HFMSE and RULM, in line with patients' and clinicians' CGI ratings; larger controlled studies are needed to confirm these findings.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768269/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407328","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Autoantibodies against N-terminal EF-hand calcium-binding protein 1 in neurological syndromes and cancer. 神经综合征和癌症中针对n端EF-hand钙结合蛋白1的自身抗体。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-14 DOI: 10.1007/s00415-026-14257-3
Madeleine Scharf, Ramona Miske, Le Duy Do, Juan Granja Lopez, Kathrin Borowski, Yvonne Müller, Christiane Radzimski, Henning Bagelmann, Monika Baloun, Lars Komorowski, Anne-Laurie Pinto, Géraldine Picard, Jerome Honnorat
{"title":"Autoantibodies against N-terminal EF-hand calcium-binding protein 1 in neurological syndromes and cancer.","authors":"Madeleine Scharf, Ramona Miske, Le Duy Do, Juan Granja Lopez, Kathrin Borowski, Yvonne Müller, Christiane Radzimski, Henning Bagelmann, Monika Baloun, Lars Komorowski, Anne-Laurie Pinto, Géraldine Picard, Jerome Honnorat","doi":"10.1007/s00415-026-14257-3","DOIUrl":"10.1007/s00415-026-14257-3","url":null,"abstract":"<p><strong>Background: </strong>Paraneoplastic neurological syndromes (PNS) are immune-mediated disorders associated with cancer and often precede tumor diagnosis. Identification of novel neural autoantigens may facilitate diagnosis and treatment.</p><p><strong>Methods: </strong>Sera or cerebrospinal fluid (CSF) from six patients showing a similar uncharacterized immunofluorescence staining pattern on rat hippocampal sections were collected. The target antigen was identified by immunoprecipitation and mass spectrometry and validated using established immunoassays.</p><p><strong>Results: </strong>N-terminal EF-hand calcium-binding protein 1 (NECAB1) was revealed as target of the autoantibodies. Antigen identification was validated by competitive tissue IIFA, CBA, Western blot and line blot with the recombinant antigen. No reactivity was observed in CBA and line blot with 100 healthy controls or CBA with 303 disease controls. All five clinically characterized patients had breast or lung cancer and presented with limbic encephalitis (n = 3), cerebellar ataxia with cognitive decline (n = 1), or sensory-motor neuronopathy (n = 1).</p><p><strong>Conclusions: </strong>NECAB1 represents a novel autoantibody target in autoimmune neurological syndromes associated with lung or breast cancer. Samples from patients with suspected neurological autoimmune disorder showing the specific hippocampal interneuron IIFA pattern should be analyzed for NECAB1 autoantibodies by CBA or line blot and cancer screening should be considered.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13769751/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407327","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anti-IgLON5 disease presenting as recurrent life-threatening laryngospasm and respiratory failure. 抗iglon5疾病表现为复发性危及生命的喉痉挛和呼吸衰竭。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-13 DOI: 10.1007/s00415-026-14249-3
Yiting Wang, Hao Zhou
{"title":"Anti-IgLON5 disease presenting as recurrent life-threatening laryngospasm and respiratory failure.","authors":"Yiting Wang, Hao Zhou","doi":"10.1007/s00415-026-14249-3","DOIUrl":"https://doi.org/10.1007/s00415-026-14249-3","url":null,"abstract":"","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Migraine: translational challenges, novel therapies and disease modification. 偏头痛:转化挑战,新疗法和疾病改造。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-13 DOI: 10.1007/s00415-026-14231-z
Leah Mistry, Alexandre Mathy, Anish Bahra
{"title":"Migraine: translational challenges, novel therapies and disease modification.","authors":"Leah Mistry, Alexandre Mathy, Anish Bahra","doi":"10.1007/s00415-026-14231-z","DOIUrl":"https://doi.org/10.1007/s00415-026-14231-z","url":null,"abstract":"<p><p>Migraine is the most common neurological disorder, which after stroke confers the greatest neurological disability in the working population. As with other disorders of brain function, pathophysiological processes are more difficult to delineate, notwithstanding the biological complexities and clinical heterogeneity of the disorder. The current review will outline the framework upon which mechanistic pathways have been predicated. It will examine bench to bedside models: what we have learned from those which have been unsuccessful and address those which have borne fruit, presenting the clinical and exploratory insights gained. In the second part the more recent successes in drug therapeutics are summarised, from clinical trials to real world observations and limitations. With this in sight, the third part emphasises the need to reframe goals towards longer-term disease modification, addressing the impact of confounding comorbidities and moving towards a biopsychosocial model of pain.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13768389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407293","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world handheld smartphone videos for nystagmus detection in acute vertigo: a feasibility study. 真实世界的手持智能手机视频检测眼球震颤急性眩晕:可行性研究。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-12 DOI: 10.1007/s00415-026-14253-7
Elvira Cortese, Benjamin Duvieusart, Haider Khan, Terence S Leung, Nehzat Koohi, Diego Kaski
{"title":"Real-world handheld smartphone videos for nystagmus detection in acute vertigo: a feasibility study.","authors":"Elvira Cortese, Benjamin Duvieusart, Haider Khan, Terence S Leung, Nehzat Koohi, Diego Kaski","doi":"10.1007/s00415-026-14253-7","DOIUrl":"https://doi.org/10.1007/s00415-026-14253-7","url":null,"abstract":"<p><strong>Background: </strong>Accurate identification of nystagmus is fundamental to the assessment of acute vertigo but remains challenging in emergency department (ED) settings. Although smartphone-based approaches have been proposed as scalable solutions, their feasibility under real-world acquisition conditions remains uncertain.</p><p><strong>Objective: </strong>This study aimed to evaluate the feasibility of detecting nystagmus from handheld smartphone videos acquired in a real-world ED.</p><p><strong>Methods: </strong>A subset of 67 videos from a published handheld smartphone-based acute vertigo dataset was analysed. A salient feature-based eye-tracking algorithm tracked stable ocular and periocular (facial) landmarks across frames. Horizontal displacement signals were extracted, and nystagmus episodes were identified through signal analysis and video verification.</p><p><strong>Results: </strong>Consistent eye-movement signals were successfully extracted from handheld smartphone recordings acquired during the acute phase of vertigo despite real-world challenges, including variable illumination, camera motion, image instability, and patient-related factors. Nystagmus patterns observed on video were accurately reflected in the corresponding signal traces, including very low-amplitude nystagmus that was barely discernible to the naked eye.</p><p><strong>Conclusions: </strong>Our findings demonstrate that handheld image acquisition using standard, low-cost smartphones can capture clinically meaningful ocular motor information in real-world emergency care settings. This proof of principle lays the groundwork for the development of more ecologically valid scalable, telehealth-compatible tools for acute vertigo assessment. Further studies are needed to automate detection and validate performance in larger prospective cohorts.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759706/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interoception predicts empathy, social anxiety and quality of life in Huntington's disease. 内感受预示着亨廷顿舞蹈症患者的共情、社交焦虑和生活质量。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-12 DOI: 10.1007/s00415-026-14248-4
Clare M Eddy, Hugh Rickards
{"title":"Interoception predicts empathy, social anxiety and quality of life in Huntington's disease.","authors":"Clare M Eddy, Hugh Rickards","doi":"10.1007/s00415-026-14248-4","DOIUrl":"https://doi.org/10.1007/s00415-026-14248-4","url":null,"abstract":"<p><p>Previous studies have documented impairments in social cognition and emotional reactivity in Huntington's disease (HD), with a few highlighting the potential impact on daily functioning and quality of life (QoL). The aims of this study were to explore how patients' self-reported social cognition was related to interoception, behavioural difficulties, carer burden and the QoL of both HD gene-carriers and their close others. A total of 36 patient-close-other dyads completed a range of scales to assess QoL, self-reported social cognition including affective empathy and perspective taking, social anxiety, interoception, patient apathy and functional capacity, and carer burden. Between group comparisons showed that gene-carriers exhibited lower QoL, emotional awareness, emotion contagion and perspective taking, as well as higher social anxiety and avoidance compared to close others. Patients' QoL scores were predicted by specific aspects of interoception and affective empathy, but most consistently by social anxiety. Interoceptive attention regulation specifically, predicted patients' functional capacity. While patient measures did not predict close-other QoL, carer burden was predicted by patients' apathy and interoception in terms of bodily listening, attention regulation and emotional awareness. These findings suggest that HD is associated with interoceptive dysfunction, which contributes to impairments in emotional awareness and affective empathy, as well as carer burden, and behavioural difficulties as perceived by both patients themselves and their close others. While both impaired interoception and social anxiety directly impact QoL in HD, interoceptive dysfunction may exert a range of indirect influences through various affective symptoms from personal distress to apathy.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 12","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759550/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149407292","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Symmetry in acute stroke imaging: a diagnostic pitfall. 急性脑卒中成像的对称性:一个诊断缺陷。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-11 DOI: 10.1007/s00415-026-14250-w
Eva S Rickers, Lukas J Volz, Gereon R Fink, Lukas Hensel
{"title":"Symmetry in acute stroke imaging: a diagnostic pitfall.","authors":"Eva S Rickers, Lukas J Volz, Gereon R Fink, Lukas Hensel","doi":"10.1007/s00415-026-14250-w","DOIUrl":"10.1007/s00415-026-14250-w","url":null,"abstract":"","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 11","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13754989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of selective orexin 2 receptor agonists in narcolepsy type 1: a systematic review and meta-analysis of randomized controlled trials. 选择性食欲素2受体激动剂治疗1型发作性睡病的疗效和安全性:一项随机对照试验的系统评价和荟萃分析
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-11 DOI: 10.1007/s00415-026-14247-5
Lu Yuan, Yan-Bing Huang, Yi-Xuan Chen, Pantila Kulachai, Shuo-Guo Jin, Hui Zheng
{"title":"Efficacy and safety of selective orexin 2 receptor agonists in narcolepsy type 1: a systematic review and meta-analysis of randomized controlled trials.","authors":"Lu Yuan, Yan-Bing Huang, Yi-Xuan Chen, Pantila Kulachai, Shuo-Guo Jin, Hui Zheng","doi":"10.1007/s00415-026-14247-5","DOIUrl":"10.1007/s00415-026-14247-5","url":null,"abstract":"<p><strong>Background: </strong>Selective orexin 2 receptor (OX2R) agonists target the orexin deficiency underlying narcolepsy type 1, but their efficacy and safety across compounds have not been quantitatively synthesized.</p><p><strong>Methods: </strong>We searched PubMed, Embase, Web of Science, and Cochrane library from inception through September 10, 2026, for randomized, double-blind, placebo-controlled trials of oral OX2R agonists in narcolepsy type 1.The primary outcomes were Maintenance of Wakefulness Test sleep latency, Epworth Sleepiness Scale score, and weekly cataplexy rate. Safety analyses included all double-blind active regimens. Adjusted mean differences and incidence rate ratios were pooled using inverse-variance random-effects models with restricted maximum-likelihood estimation and Hartung-Knapp confidence intervals. Evidence certainty was assessed using GRADE.</p><p><strong>Results: </strong>Five trials randomized 550 participants and evaluated TAK-994, oveporexton, or alixorexton over 6-12 weeks; the primary efficacy synthesis included 337 participants. Compared with placebo, OX2R agonists increased Maintenance of Wakefulness Test sleep latency by 22.7 min (95% CI 16.8-28.7; 95% prediction interval, 8.0-37.4; I<sup>2</sup> = 74.4%; low-certainty evidence), reduced epworth sleepiness scale scores (mean difference, - 9.8 points; 95% CI - 10.9 to - 8.8; I<sup>2</sup> = 0%; moderate-certainty evidence), and reduced weekly cataplexy rates by 69% (incidence rate ratio, 0.31; 95% CI 0.23-0.41; I<sup>2</sup> = 0%; moderate-certainty evidence). Urinary frequency, insomnia, urinary urgency, and salivary hypersecretion were more frequent with treatment. The TAK-994 program was terminated after hepatotoxicity.</p><p><strong>Conclusions: </strong>Short-term OX2R agonist therapy improved wakefulness, sleepiness, and cataplexy in narcolepsy type 1. Limited trials, substantial MWT heterogeneity, and short follow-up constrain class-wide and long-term safety conclusions.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 11","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149394427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subjective cognitive decline as an early marker of cognitive impairment in Parkinson's disease. 主观认知能力下降是帕金森病认知障碍的早期标志。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-10 DOI: 10.1007/s00415-026-14235-9
Gabriel Martinez Tirado, Patricia Martins Conde, Stefano Sapienza, Holger Fröhlich, Claire Pauly, Sonja R Jónsdóttir, Rejko Krüger, Jochen Klucken
{"title":"Subjective cognitive decline as an early marker of cognitive impairment in Parkinson's disease.","authors":"Gabriel Martinez Tirado, Patricia Martins Conde, Stefano Sapienza, Holger Fröhlich, Claire Pauly, Sonja R Jónsdóttir, Rejko Krüger, Jochen Klucken","doi":"10.1007/s00415-026-14235-9","DOIUrl":"10.1007/s00415-026-14235-9","url":null,"abstract":"<p><p>Cognitive impairment is one of the non-motor symptoms with the greatest impact on patients and caregiver quality of life. Given its onset and significant relevance during the prodromal phase of Parkinson's disease (PD), and its potential role as an at-risk state for cognitive impairment, this study investigated the role of subjective cognitive decline in PD (PD-SCD) as an early prognostic marker of subsequent cognitive impairment to enhance timely detection and prediction. Additionally, it evaluated how mood-related symptoms (depression, anxiety and apathy) influence this relationship. Data from 577 people with Parkinson's disease (PwPD) and 308 control participants from the Parkinson's Precision Medicine Initiative (PPMI) cohort, together with 142 PwPD from the Luxembourg Parkinson's Study cohort, were analyzed over four visits. PD-SCD, with a baseline prevalence of 21.66% in PPMI and 18.31% in the Luxembourg Parkinson's Study, was associated with an at-risk state for cognitive decline over time. Higher levels of mood-related symptoms (apathy, depression, and anxiety) were observed in the PD-SCD group compared with the people with Parkinson's disease presenting normal cognition group (PD-NC) depending on the cohort. In addition, apathy and depression were cross-sectionally associated with higher levels of subjective cognitive complaints (SCC), underscoring their role as a key feature of the PD-SCD clinical profile, without masking the association between PD-SCD and cognitive impairment. Overall, PD-SCD emerged as a relevant at-risk state of cognitive impairment in PD and as a potential dynamic tracker of cognitive impairment trajectories, highlighting its clinical relevance within the continuum of cognitive impairment in PD.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 11","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751791/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386834","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impaired discrimination of negative facial emotions in pure motor ALS. 纯运动性肌萎缩侧索硬化症患者面部负性情绪识别障碍。
IF 5.4 2区 医学
Journal of Neurology Pub Date : 2026-11-10 DOI: 10.1007/s00415-026-14241-x
Antonia Meyer, Anna Semenkova, Steven Wezel, Markus Weber, Kathi Schweikert, Regina Schläger, Janina Wendebourg, Olivier Piguet, Manfred Berres, Nathalie Braun, Dorothée Lulé, Marc Sollberger
{"title":"Impaired discrimination of negative facial emotions in pure motor ALS.","authors":"Antonia Meyer, Anna Semenkova, Steven Wezel, Markus Weber, Kathi Schweikert, Regina Schläger, Janina Wendebourg, Olivier Piguet, Manfred Berres, Nathalie Braun, Dorothée Lulé, Marc Sollberger","doi":"10.1007/s00415-026-14241-x","DOIUrl":"10.1007/s00415-026-14241-x","url":null,"abstract":"<p><strong>Background and objectives: </strong>Emotion recognition deficits in amyotrophic lateral sclerosis (ALS) remain debated. We investigated whether patients with pure motor ALS (without cognitive and behavioural disturbances) and without clinically relevant mood disturbances are impaired in discriminating negative facial emotions, using a test without ceiling effects.</p><p><strong>Methods: </strong>This cross-sectional study included 35 patients with pure motor ALS, based on the revised Strong criteria and operationalised using the Edinburgh Cognitive and Behavioural ALS Screen (ECAS), without clinically relevant mood disturbances, alongside 35 age-, sex-, and education-matched cognitively and psychiatrically healthy controls. All participants completed a shortened five-emotion version of the Facial Emotion Intensity Rating Test - Congruent and Incongruent and the Facial Sex Matching Task (FSMT), a brief screening measure of non-emotional facial discrimination.</p><p><strong>Results: </strong>Pure motor ALS patients showed poorer discrimination among negative facial emotions than healthy controls (p = 0.011, Cohen's d = 0.63). The group difference did not differ significantly across anger, fear, sadness, and disgust (p = 0.178). Similarly, the group difference in discrimination among negative emotions did not differ significantly from that in discrimination between negative emotions and happiness (p = 0.459). The two groups did not differ significantly on the FSMT.</p><p><strong>Conclusion: </strong>Discrimination of negative facial emotions was impaired in patients with pure motor ALS, suggesting that classification based on ECAS screening may underestimate social-cognitive involvement. Our findings are compatible with the concept of an ALS-frontotemporal spectrum disorder. Whether impaired emotion discrimination relates to additional cognitive or behavioural impairment remains to be determined. The clinical utility and reliability of our measure require further study.</p>","PeriodicalId":16558,"journal":{"name":"Journal of Neurology","volume":"273 11","pages":""},"PeriodicalIF":5.4,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13751581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149386833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书